secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2022-06-14T23:59:59+00:00
Accession:  0001654954-22-008336
Event type: earnings
Sentiment:  neutral
Materiality: 0.40
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv Q2 FY2022 revenue $5.0M, net income $0.2M; stable YoY
---------------------------------------------------------------------

- Revenue for Q2 ended April 30, 2022 was ~$5.0M, up ~$0.1M from prior-year quarter.
- Net income for Q2 was ~$0.2M, reflecting no significant change YoY.
- Six-month revenue ~$10.0M, net income ~$0.5M, both essentially flat YoY.
- CEO cites steady execution and focus on client services amid global uncertainties.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495422008336/0001654954-22-008336-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495422008336/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-22-008336

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer